Trinity, the leader in integrating human and artificial intelligence in life sciences commercialization, has been named to the Forbes World's Best Management Consulting Firms 2026 ranking for the third consecutive year.
The recognition underscores Trinity's commitment to delivering innovative, data-driven solutions that help pharmaceutical, biotechnology and medical technology companies make smarter decisions across the product lifecycle.
"Being recognized by Forbes for the third consecutive year is a tremendous honor and a reflection of the trust our clients place in us every day," said Scott Evangelista, Chief Executive Officer of Trinity. "The life sciences industry is evolving rapidly, driven by AI, data and increasing market complexity. We remain committed to helping our clients navigate that change with the strategic insight, scientific expertise and innovative technology they need to improve commercial performance and ultimately help patients."
Over the past year, Trinity has continued to expand its AI-enabled commercialization capabilities, introducing new solutions that help life sciences organizations transform data into actionable intelligence. Building on its strategic brand transformation, the company has further strengthened its integrated portfolio of consulting, data, analytics and technology solutions designed to accelerate decision-making and improve commercial outcomes.